CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-03). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2027 · Search date 2026-08-03 · Methodology v0.6

Hibiscus tea,
does it really help with Improvement in LDL, total cholesterol, triglycerides, and other blood lipids?

30-Second Summary
C
Evidence Grade C · 48 · Safety acceptable
Brewed-tea trials differed, and no brewed-tea-only pooled effect size was identified
Short trials identified no major safety signal or common serious adverse effect.
What the
research shows
The grade is C. Three trials of brewed tea pointed in different directions, but none reported confidence intervals for between-group change. The meta-analysis combined brewed tea with capsules and powders and provided no brewed-tea-only pooled effect, so clinical magnitude for the beverage cannot be calculated.
What the
ads claim
Pure hibiscus calyx is not Camellia sinensis and is not inherently a caffeine source, but that composition fact does not prove cholesterol lowering. Trial-product caffeine was not measured. Verdict 169 is C with 58 points for blood pressure, a different indication.
*

Useful facts when choosing a product

  • The 2011 regimen prepared a two-glass portion twice daily, but glass volume was not reported.
  • Pure hibiscus calyx is not a tea-leaf ingredient; trial-product caffeine was not measured.
  • The paper states 15 mg, about two spoons; a unit error is plausible, so no precise dose conversion was made.
Gap Measurement · Verdict 2027 · C 48
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

There were three brewed-tea trials. Mozaffari-Khosravi 2009 used black tea as an active control, and Mohagheghi 2011 also used black tea. Hajifaraji 2018 centered lifestyle guidance in both groups and lacked an adequate placebo tea, which the paper acknowledged as a limitation. All trials had fewer than 200 participants. The 2011 article literally states "15 mg, about two spoons," but a unit error is plausible, so no precise dose conversion was made from that value.

02

Why this is classified as C (48)

Only surrogate markers were measured, three brewed-tea trials differed in direction, and all omitted confidence intervals for between-group change. With no brewed-tea-only pooled magnitude, clinical size cannot be classified; small samples and comparator defects yield C with 48 points.

Counterpoint. This verdict does not merge blood-pressure claims or extract capsules with brewed hibiscus tea lipid effects.

Rejudgment record. Cross-check applied — Mixed-formulation estimates were separated from brewed-tea evidence, and missing between-group change intervals were identified

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeEXThe clinical size of the effect could not be judged

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Lower LDL from brewed hibiscus teaCThe mixed-formulation meta-analysis had no brewed-tea-only pooled estimate, so effect magnitude cannot be calculated.
Improved triglycerides and HDL from brewed hibiscus teaDThe direct 2011 brewed-tea trial found no benefit, and mixed-formulation pooled estimates were not assigned to brewed tea.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Randomized active-tea-controlled trial42Public university funding from Tehran University of Medical SciencesBlood lipids at day 30Hibiscus TG 153.5±59 to 157.5±58 and LDL 130.8±29 to 133.2±26 mg/dL; no between-group benefitDirect null evidence for brewed tea
Study 2Synthesis of 17 randomized trials, 9 reporting lipidsUniversity of Leeds scholarship and partial BBSRC supportLDL, HDL, total cholesterol, and triglyceridesMixed pooled estimate for tea, capsules, and powders; no brewed-tea-only pooled estimateShows why the mixed-formulation result cannot be assigned directly to brewed tea
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-03).

Mohagheghi A, Maghsoud S, Khashayar P, Ghazi-Khansari M. The Effect of Hibiscus Sabdariffa on Lipid Profile, Creatinine, and Serum Electrolytes: A Randomized Clinical Trial. ISRN Gastroenterol. 2011;2011:976019. PMID: 21991538.
checked
Ellis LR, Zulfiqar S, Holmes M, et al. A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers. Nutr Rev. 2022;80(6):1723-1737. DOI: 10.1093/nutrit/nuab104.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none

Cite this verdict

Hibiscus tea x improved blood lipids Evidence Grade C card
[Chamgap] Hibiscus tea x improved blood lipids — Evidence Grade C·48. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/hibiscus-tea-blood-lipids/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.